Accelerating possibilities

When we challenge inequities, we advance health care possibilities for people and communities.

Our commitment to improving patient outcomes inspires us to address global health disparities. We collaborate with partners outside the company to expand community education, increase health care provider outreach and break down barriers to care.

Two women wearing Boston Scientific shirts at an outdoor health fair smile while one holds up a medical device.

Our priorities

Improving health equity and access

Access is the key to providing medical solutions that make a meaningful difference. We work with care providers and local organizations to improve health equity by addressing disparities in underrepresented communities.

View our Close the Gap initiative to see how we are addressing health care gaps in underserved communities in the United States.

Supporting our communities

As a leader in health care, we make it a priority to help create healthier communities. Everywhere our people live and work, they contribute to their communities and our diverse programs support essential causes such STEM education and humanitarian relief.

Learn more about our community work through the Boston Scientific Foundation and our global community engagement.

2022 highlights

Our teams deepened their collaboration with nongovernmental organizations, nonprofits, health care advocates and providers to address health inequities in underrepresented populations.

121,000+

women and people of color identified in health action plans to advance equitable care in underserved  U.S. communities

$67 million

donated to fund medical research, fellowships, education and charitable organizations globally

Older dark-skinned female patient sits at a table looking into the camera.

ELEGANCE drives critical clinical insights for underrepresented patient populations

Approximately 200 million people around the world are affected by peripheral artery disease, a common circulatory problem that disproportionately affects Black men and women. Clinical studies for the disease typically do not include the common patient populations affected by the disease.

As of 2022, Boston Scientific’s ELEGANCE registry is currently exceeding its goal to increase the representation of women and underrepresented minorities in clinical trials to better reflect the populations affected by peripheral artery disease. Current enrollment spans 46 global sites and includes 43% women and 47% underrepresented minorities.

“Increasing diversity in medical research is a critical step to ensure that everyone can benefit from treatments and therapies. Now is the time to eliminate disparities in health care — once and for all.”

– Michael R. Jaff, D.O., chief medical officer and vice president, clinical affairs, technology and intervention, Peripheral Interventions